Insulet | PODD - Eps Gewinn Pro Aktie

Aktienkurs
189.56
Täglich Wechseln
-2.65 -1.38%
Monatlich
-12.24%
Jährlich
-27.29%
Q2 Prognose
185.50

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.2 1.02 May/06
FY2025Q4 Dec/2025 1.44 1.46 1.15 Feb/18
FY2025Q3 Sep/2025 1.24 1.14 0.90 Nov/06
FY2025Q2 Jun/2025 1.17 0.93 0.55 Aug/07
FY2025Q1 Mar/2025 1.02 0.77 0.23 May/08




Eps Veränderung Datum
Abbott USD 1.15 0.35 2026-03
Align Technology USD 3.29 0.68 2025-12
AtriCure USD 0.06 0.07 2025-12
Avanos Medical USD 0.29 0.07 2025-12
Baxter International USD 0.44 0.25 2025-12
Becton, Dickinson and Co. USD 2.91 1.05 2025-12
Boston Scientific USD 0.8 0 2026-03
Cardinal Health USD 2.63 0.08 2025-12
Cooper Companies USD 0.66 0.26 2025-12
Dexcom USD 0.68 0.07 2025-12
Edwards Lifesciences USD 0.78 0.2 2026-03
Eli Lilly USD 7.54 0.52 2025-12
Globus Medical USD 1.28 0.1 2025-12
ICU Medical USD 1.91 0.12 2025-12
Inogen USD -0.25 0.01 2024-09
Insulet USD 1.44 0.2 2025-12
Integra LifeSciences USD 0.83 0.29 2025-12
J&J USD 2.7 0.24 2026-03
Masimo USD -0.18 1.5 2025-12
Medtronic USD 1.36 0.29 2026-01
Merit Medical Systems USD 1.04 0.12 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Solventum Corp USD 1.68 0.18 2025-12
Stryker USD 4.47 1.28 2025-12
Tandem Diabetes Care USD -0.01 0.3 2025-12
Teleflex USD 1.93 1.74 2025-12
West Pharmaceutical Services USD 2.13 0.09 2026-03
Zimmer Biomet Holdings USD 2.42 0.52 2025-12